Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.

@article{Watzka2010ImmunoreactivityOI,
  title={Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.},
  author={Stefan B C Watzka and Irene Rauscher-P{\"o}tsch and Elisabeth B Stubenberger and V. V. Getman and Ulrike Setinek and Martin Toetsch and Ulrike Poetschger and Michael R. Mueller},
  journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery},
  year={2010},
  volume={38 3},
  pages={254-9}
}
OBJECTIVE Increased immunoreactivity of integrin-linked kinase (ILK) in the primary tumour is an adverse prognostic factor in a variety of preclinical and clinical models of human cancer. Here, we investigate the relationship between ILK immunoreactivity in primary non-small-cell lung cancer (NSCLC) and the survival after curative lung resection. METHODS Tumour specimens of 138 radically operated NSCLC patients have been retrieved from the pathology archive, mounted in tissue microarrays and… CONTINUE READING